Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Intravenous Immunoglobulin (IVIG)
Treatment for Acute hepatitis E
Typical Dosage: 0.4-1 g/kg/day for 2-5 days
Effectiveness
45%
Safety Score
65%
Clinical Trials
8
Participants
50
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
0.4-1 g/kg/day for 2-5 days
Time to Effect
Days
Treatment Duration
Few days to 2 weeks
Evidence Quality
VERY-LOWConfidence Score
30%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$10,000
Monitoring:$2,000
Side Effect Mgmt:$500
Total Annual:$12,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORQALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$31,250
Intravenous Immunoglobulin (IVIG) Outcomes
for Acute hepatitis E
Efficacy Outcomes
Overall Effectiveness
+45%
Response Rate
+40%
Common Side Effects
Headache
+15%
Fever/Chills
+10%
Allergic reactions
+3%
Nausea
+8%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov